vertigo
Conditions
Interventions
Acupuncture Group :Main Points: Baihui, Fengchi (bilateral), Naokong (bilateral), Shuigou (bilateral). Technique: Use Hua Tuo brand stainless steel disposable acupuncture needles (F0.32×25mm-50mm). A
Drug Group : Oral Betahistine Hydrochloride Tablets (4mg per tablet, manufactured by LePu Hengjiuyuan Co., Ltd., Batch No Guoyao Zhunzi H 41022374): 4mg per dose, three times daily, for a total of 2
Sponsors
Wuhu Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria 1. Meet the diagnostic criteria for posterior circulation ischemic vertigo according to Western medicine; 2. Meet the diagnostic criteria for posterior circulatschemic vertigo according to Traditional Chinese Medicine; 3. Aged between 20 and 85 years, regardless of gender; 4. Voluntarily participate in this stand sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Exclusion Criteria 1.1 Patients diagnosed with vertigo caused by posterior circulation hemorrhage; 1.2 Patients with vertigo caused by cerebra hemorrhage, intracranial space-occupying lesions, ophthalmic diseases, otogenic diseases, infectious diseases, or metabolic diseases; 1.3 Patients with coagulation or bleeding diseases; 1.4 Patients with severe diseases of the heart, kidney, lung, or liver, or organ failure; patients with mental illness; lactating or pregnant womatients with skin diseases or severe skin damage at the acupuncture sites.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dizziness Handicap Inventory (DHI) ;Dizziness Activities Rating Scale (DARS) ; | — |
Secondary
| Measure | Time frame |
|---|---|
| hemorheological parameter detection; | — |
Countries
China
Contacts
Public ContactLingmin Qian
Anhui College of Traditional Chinese Medicine
Outcome results
None listed